vs
DOCUSIGN, INC.（DOCU）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
DOCUSIGN, INC.的季度营收约是Pediatrix Medical Group, Inc.的1.7倍（$818.4M vs $493.8M），DOCUSIGN, INC.净利率更高（10.2% vs 6.8%，领先3.4%），DOCUSIGN, INC.同比增速更快（8.4% vs -1.7%）
DocuSign是总部位于美国加利福尼亚州旧金山的软件企业，为各类机构提供多设备支持的电子协议管理及电子签名相关产品。截至2025年，公司在180个国家拥有约170万客户，其处理的签名符合美国ESIGN法案、欧盟eIDAS法规要求，满足欧盟高级及合格签名标准。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
DOCU vs MD — 直观对比
营收规模更大
DOCU
是对方的1.7倍
$493.8M
营收增速更快
DOCU
高出10.1%
-1.7%
净利率更高
DOCU
高出3.4%
6.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $818.4M | $493.8M |
| 净利润 | $83.7M | $33.7M |
| 毛利率 | 79.2% | — |
| 营业利润率 | 10.4% | 9.9% |
| 净利率 | 10.2% | 6.8% |
| 营收同比 | 8.4% | -1.7% |
| 净利润同比 | 34.1% | 10.5% |
| 每股收益（稀释后） | $0.40 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCUMD
| Q4 25 | $818.4M | $493.8M | ||
| Q3 25 | $800.6M | $492.9M | ||
| Q2 25 | $763.7M | $468.8M | ||
| Q1 25 | — | $458.4M | ||
| Q4 24 | — | $502.4M | ||
| Q3 24 | — | $511.2M | ||
| Q2 24 | — | $504.3M | ||
| Q1 24 | — | $495.1M |
净利润DOCUMD
| Q4 25 | $83.7M | $33.7M | ||
| Q3 25 | $63.0M | $71.7M | ||
| Q2 25 | $72.1M | $39.3M | ||
| Q1 25 | — | $20.7M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | — | $19.4M | ||
| Q2 24 | — | $-153.0M | ||
| Q1 24 | — | $4.0M |
毛利率DOCUMD
| Q4 25 | 79.2% | — | ||
| Q3 25 | 79.3% | — | ||
| Q2 25 | 79.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率DOCUMD
| Q4 25 | 10.4% | 9.9% | ||
| Q3 25 | 8.1% | 13.8% | ||
| Q2 25 | 7.9% | 12.8% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | 3.2% |
净利率DOCUMD
| Q4 25 | 10.2% | 6.8% | ||
| Q3 25 | 7.9% | 14.5% | ||
| Q2 25 | 9.4% | 8.4% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 6.1% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | -30.3% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）DOCUMD
| Q4 25 | $0.40 | $0.40 | ||
| Q3 25 | $0.30 | $0.84 | ||
| Q2 25 | $0.34 | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $583.3M | $375.2M |
| 总债务越低越好 | — | $570.5M |
| 股东权益账面价值 | $2.0B | $865.9M |
| 总资产 | $4.0B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资DOCUMD
| Q4 25 | $583.3M | $375.2M | ||
| Q3 25 | $600.0M | $340.1M | ||
| Q2 25 | $657.4M | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $8.0M |
总债务DOCUMD
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DOCUMD
| Q4 25 | $2.0B | $865.9M | ||
| Q3 25 | $2.0B | $890.7M | ||
| Q2 25 | $2.0B | $833.8M | ||
| Q1 25 | — | $789.2M | ||
| Q4 24 | — | $764.9M | ||
| Q3 24 | — | $732.5M | ||
| Q2 24 | — | $706.5M | ||
| Q1 24 | — | $856.2M |
总资产DOCUMD
| Q4 25 | $4.0B | $2.2B | ||
| Q3 25 | $3.9B | $2.2B | ||
| Q2 25 | $3.9B | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
负债/权益比DOCUMD
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $290.3M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $262.9M | — |
| 自由现金流率自由现金流/营收 | 32.1% | — |
| 资本支出强度资本支出/营收 | 3.3% | — |
| 现金转化率经营现金流/净利润 | 3.47× | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCUMD
| Q4 25 | $290.3M | $114.1M | ||
| Q3 25 | $246.1M | $137.3M | ||
| Q2 25 | $251.4M | $137.2M | ||
| Q1 25 | — | $-117.5M | ||
| Q4 24 | — | $133.0M | ||
| Q3 24 | — | $91.8M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $-125.2M |
自由现金流DOCUMD
| Q4 25 | $262.9M | — | ||
| Q3 25 | $217.6M | — | ||
| Q2 25 | $227.8M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOCUMD
| Q4 25 | 32.1% | — | ||
| Q3 25 | 27.2% | — | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOCUMD
| Q4 25 | 3.3% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOCUMD
| Q4 25 | 3.47× | 3.39× | ||
| Q3 25 | 3.91× | 1.91× | ||
| Q2 25 | 3.49× | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | — | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCU
| Subscription And Circulation | $801.0M | 98% |
| Professional Services And Other | $17.4M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
